FiercePharma10h
Government watchdog recommends tweaks to FDA accelerated approval program
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight
The rising incidence of cancer is boosting the demand for advanced diagnostic tools, such as exosome-based diagnostics, which provide non-invasive and accurate detection methods. In addition to ...
Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely
Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...
Pharmaceutical Technology13h
Santhera launches DMD therapy in the UK following NICE nod
Santhera Pharmaceuticals has started launch preparations for its DMD drug Agamree (vamorolone) in the UK, after a ...
Bank of America Securities Remains a Hold on Kymera Therapeutics (KYMR)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Hold rating on Kymera Therapeutics (KYMR – Research ...
Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research ...